These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1862534)

  • 1. Signalling targets for anticancer drug development.
    Powis G
    Trends Pharmacol Sci; 1991 May; 12(5):188-94. PubMed ID: 1862534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor and oncogene signalling pathways as targets for rational anticancer drug development.
    Powis G; Kozikowski A
    Clin Biochem; 1991 Oct; 24(5):385-97. PubMed ID: 1760877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling pathways as targets for anticancer drug development.
    Powis G
    Pharmacol Ther; 1994; 62(1-2):57-95. PubMed ID: 7991648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of phosphatidylinositol signalling as antiproliferative agents.
    Powis G; Phil D
    Cancer Metastasis Rev; 1994 Mar; 13(1):91-103. PubMed ID: 8143348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs active against growth factor and oncogene phosphatidylinositol signalling pathways.
    Powis G
    Semin Cancer Biol; 1992 Dec; 3(6):343-50. PubMed ID: 1286155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the development of anticancer drugs that act against signalling pathways.
    Powis G
    Tumori; 1994 Apr; 80(2):69-87. PubMed ID: 8016910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell membrane and cell signals: new targets for novel anticancer drugs.
    Workman P
    Ann Oncol; 1990; 1(2):100-11. PubMed ID: 1706612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy.
    Raymond E; Faivre S; Armand JP
    Drugs; 2000; 60 Suppl 1():15-23; discussion 41-2. PubMed ID: 11129168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of phospholipid intracellular signaling as antiproliferative agents.
    Powis G; Hill SR; Frew TJ; Sherrill KW
    Med Res Rev; 1995 Mar; 15(2):121-38. PubMed ID: 7739293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction pathways: new targets in oncology.
    Sweeb RK; Beijnen JH
    Pharm World Sci; 1993 Dec; 15(6):233-42. PubMed ID: 8298582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances with phospholipid signalling as a target for anticancer drug development.
    Powis G; Berggren M; Gallegos A; Frew T; Hill S; Kozikowski A; Bonjouklian R; Zalkow L; Abraham R; Ashendel C
    Acta Biochim Pol; 1995; 42(4):395-403. PubMed ID: 8852330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key cancer cell signal transduction pathways as therapeutic targets.
    Bianco R; Melisi D; Ciardiello F; Tortora G
    Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/Akt signalling pathway and cancer.
    Fresno Vara JA; Casado E; de Castro J; Cejas P; Belda-Iniesta C; González-Barón M
    Cancer Treat Rev; 2004 Apr; 30(2):193-204. PubMed ID: 15023437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anticancer drug discovery.
    Buolamwini JK
    Curr Opin Chem Biol; 1999 Aug; 3(4):500-9. PubMed ID: 10419854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Molecular Targets of Anticancer Therapy - Current Status and Perspectives.
    Zajac M; Muszalska I; Jelinska A
    Curr Med Chem; 2016; 23(37):4176-4220. PubMed ID: 27528054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challenges.
    Hilgard P; Pohl J; Engel J
    J Cancer Res Clin Oncol; 1997; 123(5):286-7. PubMed ID: 9201252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Signal transduction by protein tyrosine kinases and antitumor agents].
    Mao YJ; Li HH; Li JF; Shen JS
    Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel targets for anticancer treatment development in colorectal cancer.
    Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
    Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.